Replies to post #66747 on Biotech Values

[read_this_n0w]

Mostly broad re-summary. Good to use to get some people up to speed quickly.

personally i was unaware of Momenta

"But companies such as Cambridge,
Massachusetts–based Momenta, which specializes
in characterization, say they have the
expertise to identify any differences between a
biogeneric and its reference product, and that
these data can be used to direct further development
and review of the drug. “What we’re doing
is what Congress says can’t be done,” says Craig
Wheeler, CEO of Momenta."